Kan Chen

No ORCID on file · 2 papers in corpus
lab-animal 2020
Drug design, development and therapy ·doi:10.2147/dddt.s252681

INTRODUCTION: The aim of this study was to screen the leading compounds of natural origin with anti-angiogenic potential and to investigate their anti-angiogenic mechanism preliminarily. MATERIALS AND METHODS: An initial screening of 240 c…

lab-animal 2018
Experimental and therapeutic medicine ·doi:10.3892/etm.2018.6748

The present study aimed to screen natural products with anti-angiogenic potential from the Natural Products Collection of MicroSource. The anti-angiogenic activity of 240 natural products was assessed using the zebrafish line Tg(fli1a: EGFP…